https://www.selleckchem.com/pr....oducts/epacadostat-i
To compare the neuropsychiatric symptoms (NPS) of patients with mild cognitive impairment with Lewy bodies (MCI-L with those with mild cognitive impairment due to Alzheimer's disease (MCI-AD). Subjects with probable MCI-LB ( = 53), MCI-AD ( = 6, dementia with Lewy bodies (DL ( = 97) and AD ( = 202) were recruited. All were older than 60 years. Neuropsychiatric profiles were evaluated by the Neuropsychiatric Inventory (NPI). The Lewy Body Neuropsychiatric Supportive Symptom Count (LBNSSC) was used to assess give
Like
Comment
Share
